TEM: רווח נקי למניה (EPS TTM) Tempus AI Inc

Tempus AI, Inc (TEM) demonstrates high stability, as oncology diagnostic costs are minimally affected by economic crises. The company is creating a unique precision medicine environment where every new profile enhances the platform's value. This 12-month EPS chart illustrates an aggressive data market capture strategy, and -1.06 shows the current earnings per share metric.

For Tempus AI, Inc (TEM), a precision medicine pioneer with a unique genomic database, EPS TTM reflects the actual earnings per share by dividing the total annual net income by the total number of outstanding securities. By analyzing the rolling 12-month EPS value, an investor assesses the monetization efficiency of AI solutions in oncology and determines the business's resilience to market volatility.